Paxman AB (publ) (STO:PAX)

Sweden flag Sweden · Delayed Price · Currency is SEK
52.60
+1.00 (1.94%)
At close: Mar 4, 2026
-21.49%
Market Cap 1.20B
Revenue (ttm) 323.56M
Net Income (ttm) -16.72M
Shares Out 23.27M
EPS (ttm) -0.76
PE Ratio n/a
Forward PE 29.15
Dividend n/a
Ex-Dividend Date n/a
Volume 23,270
Average Volume 24,064
Open 50.60
Previous Close 51.60
Day's Range 49.70 - 53.00
52-Week Range 41.00 - 85.80
Beta 0.45
RSI 58.39
Earnings Date Feb 20, 2026

About Paxman AB

Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various cancer centers and hospitals. The company has collaborated with the University of Huddersfield and the University of Leeds to develop a wearable medical cooling device; and the National University Hospital of Singapore for the development of a cooling and compression system. Paxman AB (publ) was founded in 1996 and is headquartered in Karlshamn, Sweden. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1996
Employees 142
Stock Exchange Nasdaq Stockholm
Ticker Symbol PAX
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.